Trial intelligence / Profile preview

Task Shifting for Depression in HIV (INDEPTH-Uganda)

NCT02056106Phase 4Completed

Sponsor
RanD
Start
Jan 2013
Primary completion
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of antidepressant (TDDS/ODF) in major depressive disorder (MDD) (2 arms), sponsored by RanD. Primary endpoints: Depression diagnostic evaluation at Month 12, Antidepressant prescription at Month 12 and 1 more. Started Jan 2013; status: completed.

02

Drugs

antidepressant (TDDS/ODF)
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT02056106.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02056106.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call